Neuroprotective effects of erythropoietin against hypoxic injury via modulation of the mitogen-activated protein kinase pathway and apoptosis

PURPOSE: Hypoxic-ischemic encephalopathy is a significant cause of neonatal morbidity and mortality. Erythropoietin (EPO) is emerging as a therapeutic candidate for neuroprotection. Therefore, this study was designed to determine the neuroprotective role of recombinant human EPO (rHuEPO) and the pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Ji Eun, Park, Jae Hyun, Kim, Chun Soo, Lee, Sang Lak, Chung, Hai Lee, Kim, Woo Taek, Lee, Eun Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pediatric Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500386/
https://www.ncbi.nlm.nih.gov/pubmed/28690645
http://dx.doi.org/10.3345/kjp.2017.60.6.181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500386/
https://www.ncbi.nlm.nih.gov/pubmed/28690645
http://dx.doi.org/10.3345/kjp.2017.60.6.181

Ejemplares similares